Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.

Thom S, Poulter N, Field J, Patel A, Prabhakaran D, Stanton A, Grobbee DE, Bots ML, Reddy KS, Cidambi R, Bompoint S, Billot L, Rodgers A; UMPIRE Collaborative Group..

JAMA. 2013 Sep 4;310(9):918-29. doi: 10.1001/jama.2013.277064. Erratum in: JAMA. 2013 Oct 9;310(14):1507. Naik, Nitish [added]; Reddy, Srinivas [added]; Balaji, Sham [corrected to Achuthan, Shyambalaji]; Damodra Rao, Modem [corrected to Damodra Rao, Kodem].

PMID:
24002278
2.

Lower postprandial glucose responses at baseline and after 4 weeks use of a diabetes-specific formula in diabetes type 2 patients.

Lansink M, van Laere KM, Vendrig L, Rutten GE.

Diabetes Res Clin Pract. 2011 Sep;93(3):421-9. doi: 10.1016/j.diabres.2011.05.019. Epub 2011 Jun 15.

3.

An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.

PILL Collaborative Group., Rodgers A, Patel A, Berwanger O, Bots M, Grimm R, Grobbee DE, Jackson R, Neal B, Neaton J, Poulter N, Rafter N, Raju PK, Reddy S, Thom S, Vander Hoorn S, Webster R.

PLoS One. 2011;6(5):e19857. doi: 10.1371/journal.pone.0019857. Epub 2011 May 25.

5.

Evaluation of a multidisciplinary treatment for patients with chronic non-specific upper-limb musculoskeletal disorders: a pilot study.

Schakenraad CH, Vendrig L, Sluiter JK, Veenstra W, Frings-Dresen MH.

Occup Med (Lond). 2004 Dec;54(8):576-8.

PMID:
15576873
6.

Validating the MPI-DLV using experience sampling data.

Lousberg R, Schmidt AJ, Groenman NH, Vendrig L, Dijkman-Caes CI.

J Behav Med. 1997 Apr;20(2):195-206.

PMID:
9144040

Supplemental Content

Loading ...
Support Center